• 13.04.2017

This week, AmCham met with the Vice-ministry of Health and representatives from both the Ministry of Health and the Medicines and Medical Devices Agency to discuss the draft Law on drugs. In particular, AmCham voiced concerns that the implementation of such measures as parallel imports and online sales of medicines, in the absence of necessary safeguards, will significantly increase the risk of counterfeit or unsafe drugs entering the national market.

Additionally, it has been highlighted that the draft law fails to specify relevant exemptions applicable upon authorizing medicines that have a prior registration in EU countries.